Comparative Pharmacology
Head-to-head clinical analysis: BUTALBITAL ACETAMINOPHEN CAFFEINE AND CODEINE PHOSPHATE versus ESGIC PLUS.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BUTALBITAL ACETAMINOPHEN CAFFEINE AND CODEINE PHOSPHATE versus ESGIC PLUS.
BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE vs ESGIC-PLUS
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Butalbital is a barbiturate that enhances GABA-A receptor activity, producing sedation; acetaminophen inhibits cyclooxygenase (COX) enzymes centrally, reducing pain and fever; caffeine is a nonselective adenosine receptor antagonist, causing vasoconstriction and central nervous system stimulation; codeine is an opioid agonist at mu-opioid receptors, providing analgesia and antitussive effects.
Esgic-Plus is a combination of acetaminophen (analgesic/antipyretic via COX inhibition and central action), butalbital (barbiturate that enhances GABA-A receptor activity), and caffeine (adenosine receptor antagonist and CNS stimulant). The mechanism for treating tension headache is attributed to the synergistic effects of these components.
1-2 capsules orally every 4 hours as needed for pain, not exceeding 6 capsules per day. Each capsule contains butalbital 50 mg, acetaminophen 300 mg, caffeine 40 mg, and codeine phosphate 30 mg.
1-2 capsules (acetaminophen 500 mg, butalbital 50 mg, caffeine 40 mg per capsule) orally every 4 hours as needed, not exceeding 6 capsules per day.
None Documented
None Documented
Butalbital: ~35 hours (range 30-50 h), long-acting barbiturate; Acetaminophen: ~2-3 hours; Caffeine: ~3-5 hours in adults; Codeine: ~2.5-3.5 hours; note that codeine's active metabolite morphine has half-life ~2-3 h, and renal impairment prolongs half-life of butalbital and codeine.
Butalbital: 35-70 hours in adults; prolonged in hepatic/renal impairment. Acetaminophen: 2-3 hours in adults; extended in overdose (potential hepatotoxicity). Caffeine: 3-6 hours in adults; increased in pregnancy or liver disease.
Butalbital: ~60-70% renal as unchanged drug and metabolites; Acetaminophen: ~90-100% renal within 24 hours (2-5% unchanged, rest as glucuronide and sulfate conjugates); Caffeine: ~1-2% renal unchanged, rest metabolized; Codeine: ~90% renal (10% unchanged, 40% as codeine-6-glucuronide, rest as morphine and norcodeine metabolites). Biliary/fecal excretion minimal for all components.
Butalbital: 60-90% renal as unchanged drug and metabolites, 10-40% fecal via biliary elimination. Acetaminophen: ~85% renal as glucuronide (45-55%), sulfate (25-35%), and cysteine conjugates (4-15%); 2-4% unchanged. Caffeine: ~85-90% renal as metabolites (1-methylxanthine, 1-methyluric acid, 1,7-dimethylxanthine); 1-3% unchanged.
Category D/X
Category C
Barbiturate + Analgesic
Barbiturate/Narcotic Combination